Sub-1.4 cm3 capsule for detecting labile inflammatory biomarkers in situ

M. E. Inda-Webb, M. Jimenez, Q. Liu, N. V. Phan, J. Ahn, C. Steiger, A. Wentworth, A. Riaz, T. Zirtiloglu, K. Wong, K. Ishida, N. Fabian, J. Jenkins, J. Kuosmanen, W. Madani, R. McNally, Y. Lai, A. Hayward, M. Mimee, P. Nadeau, A. P. Chandrakasan, G. Traverso (), R. T. Yazicigil () and T. K. Lu ()
Additional contact information
M. E. Inda-Webb: Massachusetts Institute of Technology
M. Jimenez: Massachusetts Institute of Technology
Q. Liu: Boston University
N. V. Phan: Massachusetts Institute of Technology
J. Ahn: Massachusetts Institute of Technology
C. Steiger: Massachusetts Institute of Technology
A. Wentworth: Massachusetts Institute of Technology
A. Riaz: Boston University
T. Zirtiloglu: Boston University
K. Wong: Brigham and Women’s Hospital, Harvard Medical School
K. Ishida: Massachusetts Institute of Technology
N. Fabian: Massachusetts Institute of Technology
J. Jenkins: Massachusetts Institute of Technology
J. Kuosmanen: Massachusetts Institute of Technology
W. Madani: Massachusetts Institute of Technology
R. McNally: Brigham and Women’s Hospital, Harvard Medical School
Y. Lai: Massachusetts Institute of Technology
A. Hayward: Massachusetts Institute of Technology
M. Mimee: The University of Chicago
P. Nadeau: Analog Devices
A. P. Chandrakasan: MIT
G. Traverso: Massachusetts Institute of Technology
R. T. Yazicigil: Boston University
T. K. Lu: Massachusetts Institute of Technology

Nature, 2023, vol. 620, issue 7973, 386-392

Abstract: Abstract Transient molecules in the gastrointestinal tract such as nitric oxide and hydrogen sulfide are key signals and mediators of inflammation. Owing to their highly reactive nature and extremely short lifetime in the body, these molecules are difficult to detect. Here we develop a miniaturized device that integrates genetically engineered probiotic biosensors with a custom-designed photodetector and readout chip to track these molecules in the gastrointestinal tract. Leveraging the molecular specificity of living sensors1, we genetically encoded bacteria to respond to inflammation-associated molecules by producing luminescence. Low-power electronic readout circuits2 integrated into the device convert the light emitted by the encapsulated bacteria to a wireless signal. We demonstrate in vivo biosensor monitoring in the gastrointestinal tract of small and large animal models and the integration of all components into a sub-1.4 cm3 form factor that is compatible with ingestion and capable of supporting wireless communication. With this device, diseases such as inflammatory bowel disease could be diagnosed earlier than is currently possible, and disease progression could be more accurately tracked. The wireless detection of short-lived, disease-associated molecules with our device could also support timely communication between patients and caregivers, as well as remote personalized care.

Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41586-023-06369-x Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:620:y:2023:i:7973:d:10.1038_s41586-023-06369-x

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-023-06369-x

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().